References

  1. WHO. Measles. 2017. Accessed 2017 Apr 10

  2. Akande TM. A review of measles vaccine failure in developing countries. Nigerian Medical Practitioner. 2007;52:112-6. Google Scholar

  3. Ibrahim BS, Gana GJ, Mohammed Y, Bajoga UA, Olufemi AA, Umar AS et al. Outbreak of measles in Sokoto State North-Western Nigeria, three months after a supplementary immunization campaign: an investigation report 2016. Australian Medical Journal. 2016;9(9):324-335. Google Scholar

  4. CDC. Epidemiology and Prevention of Vaccine-Preventable Diseases. Accessed 2017 Apr 11

  5. CDC. Measles (Rubeola). Complications of Measles. Accessed 2017 Apr 11

  6. Merck Manuals Professional version. Measles (Rubeola; Morbilli; 9-Day Measles). Accessed 2017 Apr 11

  7. Kabra SK, Lodha R. Antibi otics for preventing complications in children with measles. In: Kabra SK, editor. Cochrane Database Syst Rev. Chichester, UK: John Wiley & Sons, Ltd; 2013

  8. WHO. Number of reported measles cases with onset date from Oct 2015 to Mar 2016 (6M period). Accessed 2017 Apr 11

  9. Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1459-544. PubMed | Google Scholar

  10. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015 Jan 10;385(9963):117-71. Epub 2014 Dec 18. Google Scholar

  11. PAHO WHO. Region of the Americas is declared free of measles. Accessed 2017 Apr 11

  12. Ludlow M, McQuaid S, Milner D, de Swart RL, Duprex WP. Pathological consequences of systemic measles virus infection. J Pathol. 2015 Jan;235(2):253-65. PubMed | Google Scholar

  13. Murray CJL, Lopez AD. Global mortality, disability and the contribution of risk factors: global burden of disease study. Lancet. 1997;349(9063):1436-42. PubMed | Google Scholar

  14. Perry RT, Halsey NA. The clinical significance of measles: a review. J Infect Dis. 2004 May 1;189 Suppl 1:S4-16. PubMed | Google Scholar

  15. WHO/UNICEF Joint statement. WHO reducing measles mortality in emergencies. 2004. Accessed 2017 Apr 11

  16. Halsey NA, Boulos R, Mode F, Andre J, Bowman L, Yaeger RG et al. Response to measles vaccine in Haitian infants 6 to 12 months old: influence of maternal antibodies, malnutrition, and concurrent illnesses. N Engl J Med. 1985;313:544-9. PubMed | Google Scholar

  17. Sommer A, West KP. Vitamin A deficiency: health, survival and vision. Oxford University Press, New York. 1996. 438p.

  18. Salama P, Assefa F, Talley L, Spiegel P, van der Veen A, Gotway CA. Malnutrition, measles, mortality, and the humanitarian response during a famine in Ethiopia. JAMA. 2001;286(5):563-571. PubMed | Google Scholar

  19. Nigeria. Nigeria demographic and health survey 2013. 2014. Accessed 2017 Apr 11

  20. Schimmer B, Ihekweazu C. Polio eradication and measles immunisation in Nigeria. Lancet Infect Dis. 2006 Feb;6(2):63-5. PubMed | Google Scholar

  21. WHO. Regional Office for Africa. Accessed 2017 Apr 11

  22. Onyiriuka AN. Clinical profile of children presenting with measles in a Nigerian secondary health-care institution. J Infect Dis Immun. 2011;3(6):112-6. Google Scholar

  23. Ogunmekan DA, Bracken P, Marshall WC. A seroepidemiological study of measles infection in normal and handicapped persons in Lagos, Nigeria. J Trop Med Hyg. 1981 Aug;84(4):175-8. PubMed | Google Scholar

  24. Jalal-Eddeen Abubakar Saleh. Trends of measles in Nigeria: a systematic review. Sahel Med J. 2016;19(1):5-11. Google Scholar

  25. Nation Population Commission of Nigeria. National Census Data. 2015. Accessed 2016 Apr 28

  26. CIA. The World Factbook. 2016. Accessed 2017 13

  27. WHO. WHO-recommended surveillance standard of measles. 2014. Accessed 2017 Aug 30

  28. Fatiregun AA, Odega CC. Representativeness of suspected measles cases reported in a southern district of Nigeria. Asian Pac J Trop Med. 2013 Feb;6(2):131-4. PubMed | Google Scholar

  29. Peter KB, Ademola AS, Oyeku OA. Effects of supplemental measles immunization on cases of measles admitted at the Wesley Guild Hospital, Ilesa, Nigeria. Afr Health Sci. 2014 Mar;14(1):131-5. PubMed | Google Scholar

  30. World Health Organization. Regional Office for Africa. Paramount rulers in the Northern Nigeria recommit to improving health indicators in the region. Accessed 2017 Aug 30

  31. Centers for Disease Control (CDC). Measles prevention. MMWR Suppl. 1989 Dec 29;38(9):1-18. PubMed | Google Scholar

  32. Wollum A, Burstein R, Fullman N, Dwyer-Lindgren L, Gakidou E. Benchmarking health system performance across states in Nigeria: a systematic analysis of levels and trends in key maternal and child health interventions and outcomes, 2000-2013. BMC Medicine.2015;13:208. Google Scholar